A recent clinical trial, funded in part by NIA, explored the impact of two drugs, gantenerumab or solanezumab, on symptoms and Alzheimer’s disease biomarkers among people with a rare type of early-onset dementia caused by genetic mutations. Researchers conducting the study…
Read More Study Explores Drug Treatments for Early-onset Alzheimer’s disease
Interested in volunteering for research on Alzheimer’s, related dementias, and cognitive health?
Interested in volunteering for research on Alzheimer’s, related dementias, and cognitive health?
Check out the latest advances in Alzheimer's and related dementias research.
Check out the latest in aging advances, research, and events happening at NIA:
New study finds that people with #dementia were twice as likely to get COVID-19 compared to people without dementia.
Looking for #Alzheimers and related dementias #clinicaltrials? Find the latest information here:
Interested in volunteering for research on Alzheimer’s, related dementias, and cognitive health? Search for clinical trials and studies near you with NIA’s Clinical Trials Finder. New and featured studies Click on the trial name for details, including contact information. Biomarkers and Brain…
Read More Studies recruiting healthy volunteers, people with dementia or mild cognitive impairment
Study sections adapt to changing scienceRené Etcheberrigaray, Senior Scientific Advisor, Division of Extramural ActivitiesThe NIH Center for Scientific Review (CSR) reviews approximately 70% of the applications received by NIH, including those assigned to NIA. But as science advances, so must peer…
Check out the latest in aging advances, research, and events happening at NIA: New report on indicators of well-being among older Americans — Federal agencies, including NIA, identified and updated 40 indicators of well-being in the areas of population, economics, health…
English
Chinese (Simplified)
Chinese (Traditional)
Hindi
Polish
Russian
Spanish